Papers: 10.1371/journal.pone.0227940

https://doi.org/10.1371/journal.pone.0227940

TLR5 agonist entolimod reduces the adverse toxicity of TNF while preserving its antitumor effects

Cited by: 17
Author(s): Gary Haderski, Bojidar Kandar, Craig M. Brackett, Ilia M. Toshkov, Christopher P. Johnson, Geraldine Paszkiewicz, Venkatesh Natarajan, Anatoli S. Gleiberman, Andrei V. Gudkov, Lyudmila Burdelya
Published: almost 7 years ago

Software Mentions 1